title: Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia.
abstract: OBJECTIVE
  Hypoxia-inducible factor 1 (HIF-1) regulates the expression of angiogenic growth factors. We analyzed the effect of intramuscular (i.m.) delivery of AdCA5, an adenovirus encoding a constitutively active form of the HIF-1alpha subunit, in a novel model of limb ischemia.
  
  
  METHODS
  AdCa5 or AdLacZ (6 x 10(8) pfu) was injected into male New Zealand White rabbits that were untreated or subjected to occlusion of the left superficial femoral artery by endovascular coils. Expression of mRNAs was quantified 1, 3, and 7 days after adenovirus injection into rabbits without occlusion. Calf blood pressure (BP), angiography, and immunohistochemical analyses were performed 14 days after arterial occlusion and adenovirus injection.
  
  
  RESULTS
  AdCA5 increased the expression of HIF-1alpha, monocyte chemotactic protein-1, placental growth factor, platelet-derived growth factor B, stromal-derived factor 1alpha, and vascular endothelial growth factor (VEGF) mRNA as well as HIF-1alpha and VEGF protein. On day 14, AdCA5-injected limbs showed improved calf BP ratios (0.89+/-0.13 vs. 0.51+/-0.05, p=0.02), angiographic perfusion scores (3.50+/-0.56 vs. 8.33+/-1.31, p=0.007), and distal deep femoral artery diameter ratio (1.84+/-0.25 vs. 0.93+/-0.22, p=0.02) relative to those receiving AdLacZ. The capillary/myocyte ratio (0.93+/-0.03 vs. 0.78+/-0.06, p=0.04) and arterial luminal area (0.32+/-0.05 mm2 vs. 0.21+/-0.03 mm2, p=0.04) were significantly increased in the AdCA5 group.
  
  
  CONCLUSIONS
  In a model that resembles atherosclerotic obstruction of peripheral arteries in patients, the i.m. administration of AdCA5 promoted arteriogenic and angiogenic responses.
authors.affiliation: The Russell H. Morgan Department of Radiology and Radiological Science, Division of Vascular and Interventional Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
authors.forename: Tarak H
authors.initials: TH
authors.lastname: Patel
authors.forename: Hideo
authors.initials: H
authors.lastname: Kimura
authors.forename: Clifford R
authors.initials: CR
authors.lastname: Weiss
authors.forename: Gregg L
authors.initials: GL
authors.lastname: Semenza
authors.forename: Lawrence V
authors.initials: LV
authors.lastname: Hofmann
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000792:Angiography; D000818:Animals; D001158:Arteries / Q000473:pathology; D003097:Collateral Circulation; D004730:Endothelium, Vascular / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000473:pathology; D005121:Extremities / Q000098:blood supply*; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000008:administration & dosage; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use*; D007091:Image Processing, Computer-Assisted; D007511:Ischemia / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000473:pathology; D008297:Male; D023421:Models, Animal; D011817:Rabbits; D012039:Regional Blood Flow; D014161:Transduction, Genetic / Q000379:methods
chemical_list: D051795:Hypoxia-Inducible Factor 1, alpha Subunit